• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

Propanoic acid, 2,2-difluoro-3-oxo-, ethyl ester (CAS No. 150731-03-6): A Comprehensive Overview

Propanoic acid, 2,2-difluoro-3-oxo-, ethyl ester, identified by its CAS number 150731-03-6, is a fluorinated carboxylic acid ester that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, characterized by its unique structural and chemical properties, has found applications in various scientific domains, particularly in the development of novel synthetic methodologies and biologically active molecules.

The molecular structure of Propanoic acid, 2,2-difluoro-3-oxo-, ethyl ester consists of a propanoic acid backbone with two fluorine atoms substituting at the α-carbon position and an oxygen atom at the β-carbon position forming a ketone group. The ethyl ester moiety further modifies its reactivity and solubility characteristics. This specific arrangement of functional groups imparts distinct chemical behavior, making it a valuable intermediate in organic synthesis and a potential candidate for drug discovery programs.

In recent years, the interest in fluorinated compounds has surged due to their enhanced metabolic stability and improved binding affinity to biological targets. The presence of two fluorine atoms in Propanoic acid, 2,2-difluoro-3-oxo-, ethyl ester contributes to its potential as a building block for the synthesis of fluorinated pharmaceuticals. Researchers have leveraged its structural features to develop novel molecules with therapeutic potential in areas such as oncology and anti-inflammatory treatments.

One of the most compelling aspects of this compound is its role in facilitating cross-coupling reactions, which are fundamental to modern synthetic organic chemistry. The electron-withdrawing nature of the fluorine atoms and the presence of a reactive ketone group make it an ideal candidate for palladium-catalyzed reactions. These reactions are widely used in the pharmaceutical industry to construct complex molecular architectures efficiently. For instance, studies have demonstrated its utility in the synthesis of biaryl compounds, which are prevalent in many active pharmaceutical ingredients (APIs).

The ethyl ester functionality also contributes to the compound's versatility, allowing for further derivatization into various pharmacophores. Researchers have explored its use in generating heterocyclic compounds, which are known for their broad spectrum of biological activities. By incorporating this compound into multi-step synthetic routes, scientists have been able to produce structurally diverse molecules with potential applications in medicinal chemistry.

Advances in computational chemistry have further enhanced the understanding of Propanoic acid, 2,2-difluoro-3-oxo-, ethyl ester's reactivity. Molecular modeling studies have provided insights into how the fluorine atoms influence electronic distributions and steric interactions within molecules. These insights are crucial for designing experiments aimed at optimizing synthetic pathways and improving yields. Additionally, computational predictions have helped identify new reaction conditions that might not be apparent through traditional experimental approaches.

In the context of drug discovery, the compound's unique properties make it a promising scaffold for developing small-molecule inhibitors. Fluorinated derivatives have shown promise in modulating enzyme activity and receptor binding affinity. For example, research has indicated that compounds incorporating this motif can exhibit enhanced selectivity towards certain therapeutic targets compared to their non-fluorinated counterparts. This selectivity is often critical for minimizing side effects and improving overall drug efficacy.

The synthesis of Propanoic acid, 2,2-difluoro-3-oxo-, ethyl ester itself presents an interesting challenge due to the need for precise functional group control. Modern synthetic methodologies have enabled more efficient access to this compound compared to earlier techniques. Catalytic processes and green chemistry principles have been employed to reduce waste and improve atom economy during production. Such advancements align with broader industry trends toward sustainable chemical manufacturing.

The biological activity of derivatives of this compound has also been explored in preclinical studies. While not yet approved for human use, early findings suggest that certain analogs may possess anti-inflammatory or antiviral properties. These preliminary results warrant further investigation into their potential as lead compounds for new therapies. Collaborative efforts between synthetic chemists and biologists are essential for translating these findings into tangible medical benefits.

The future direction of research involving Propanoic acid, 2,2-difluoro-3-oxo-, ethyl ester is likely to be shaped by emerging technologies such as flow chemistry and automation. These innovations promise to accelerate the discovery and optimization process by enabling rapid screening of reaction conditions and scalability improvements. As these technologies mature, they will provide researchers with powerful tools to explore the full potential of this versatile intermediate.

In conclusion, Propanoic acid, 2,2-difluoro-3-oxo-, ethyl ester (CAS No. 150731-03-6) represents a significant advancement in synthetic chemistry with far-reaching implications for drug development. Its unique structural features make it a valuable tool for constructing complex molecules with therapeutic potential. As research continues to uncover new applications and refine synthetic methodologies, this compound is poised to play an increasingly important role in the pharmaceutical industry.

• 28781-85-3(ethyl 2,2-difluoropropanoate)
• 379-95-3(Dimethyl difluoromalonate)
• 680-65-9(diethyl difluoromalonate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)